EAM Investors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-214,898
Closed -$1.53M 387
2017
Q3
$1.53M Buy
+214,898
New +$1.53M 0.2% 226
2014
Q3
Sell
-168,513
Closed -$2.59M 388
2014
Q2
$2.59M Sell
168,513
-62,271
-27% -$958K 0.49% 34
2014
Q1
$3.93M Sell
230,784
-12,131
-5% -$207K 0.71% 11
2013
Q4
$3.15M Buy
242,915
+11,016
+5% +$143K 0.56% 26
2013
Q3
$2.34M Sell
231,899
-11,230
-5% -$113K 0.47% 52
2013
Q2
$1.82M Buy
+243,129
New +$1.82M 0.39% 67